Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Actelion Pharmaceuticals Ltd | 20 |
| 2 | Scripps Research Institute | 5 |
| 3 | JNC Corp | 4 |
| 4 | L'Oréal SA | 4 |
| 5 | Novartis AG | 4 |
| 6 | Medtronic Inc | 2 |
| 7 | City of Hope | 1 |
| 8 | University of Florida | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 37 |
| 2 | A61P | Therapeutic activity (drug indications) | 36 |
| 3 | C07D | Heterocyclic compounds | 29 |
| 4 | A61Q | Cosmetics, personal care | 4 |
| 5 | G01N | Investigating / analysing materials | 4 |
| 6 | C07K | Peptides | 3 |
| 7 | A61M | Devices for introducing media into the body | 2 |
| 8 | Y02A | Climate change adaptation | 2 |
| 9 | C07B | General methods of organic chemistry | 1 |
| 10 | Y10T | Cross-reference (technical subjects) | 1 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Neurotransmitter Receptor Influence on Behavior | 2 |
| 2 | Acupuncture Treatment Research Studies | 1 |
| 3 | Epilepsy research and treatment | 1 |
| 4 | Nausea and vomiting management | 1 |
| 5 | Neuroscience and Neuropharmacology Research | 1 |
| 6 | Olfactory and Sensory Function Studies | 1 |
| 7 | Sulfur Compounds in Biology | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Anders Björklund | Lund University | 9 |
| 2 | H. G. Baumgarten | Universität Hamburg | 9 |
| 3 | Kjell Hole | University of Bergen | 7 |
| 4 | Leif Wiklund | Lund University | 8 |
| 5 | H. P. Klemm | Universität Hamburg | 6 |
| 6 | Odd‐Geir Berge | University of Bergen | 6 |
| 7 | Berndt Ehinger | Lund University | 5 |
| 8 | D.B. Beleslin | 5 | |
| 9 | Geoffrey A. Head | Baker Heart and Diabetes Institute | 5 |
| 10 | H. Schloßberger | Max Planck Institute of Biochemistry | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Serotonin neurons of the midbrain raphe: Ascending projections | 1978 | 803 | Neurotransmitter Receptor Influence on Behavior |
| Release of substance P from the cat spinal cord. | 1987 | 371 | Anesthesia and Pain Management |
| The interplexiform cell system - I. Synapses of the dopaminergic neurons of the goldfish retina | 1978 | 355 | Neuroscience and Neuropharmacology Research |
| Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; Their roles in local alterations of cerebrospinal fluid and vasomotor activity | 1976 | 325 | Neuroscience and Neuropharmacology Research |
| Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat | 1975 | 317 | Neurotransmitter Receptor Influence on Behavior |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of 3-(2-aminoethyl)-1H-indole-5,6-diol?
Which organization holds the most patents related to this compound?
What are the primary patent classifications associated with this compound?
What research topics are associated with publications on this compound?
What is the publication output trend for research on this compound?